Urol. praxi. 2022;23(1):38-43 | DOI: 10.36290/uro.2022.014

How frequent and dangerous is overactive bladder syndrome after radical prostatectomy?

MUDr. Lukáš Holub, MUDr. Petr Hušek, Ph.D., FEBU, MUDr. Jiří Špaček, prof. MUDr. Miloš Broďák, Ph.D.
Urologická klinika FN a LF UK Hradec Králové

Introduction: Hyperactive bladder syndrome after radical prostatectomy is a less common but serious disease that can have a major negative impact on quality of life.

Method: A group of 500 patients after robot-assisted radical prostatectomy in 2016-2018 was evaluated. Hyperactive bladder was assessed on the basis of micturition diaries 3 and 6 months after surgery.

Results: The median follow-up was 36 months. Overactive bladder syndrome was diagnosed in 15 (3 %) patients. First-generation anticholinergic therapy was effective in 12 (80 %) patients. In three (20 %) patients, treatment was changed to solifenacin, which remained effective. After 6 months, the treatment was effective and did not need to be changed in the long term, Conclusion: The incidence of overactive bladder syndrome was low in our cohort (3 %), which was less than in similar published studies. In most patients (80 %), first-generation anticholinergic therapy was effective. If the therapeutic effect was insufficient or side effects occurred, treatment with solifenacin was effective.

Keywords: hyperactive bladder, radical prostatectomy, anticholinergics.

Published: March 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holub L, Hušek P, Špaček J, Broďák M. How frequent and dangerous is overactive bladder syndrome after radical prostatectomy? Urol. praxi. 2022;23(1):38-43. doi: 10.36290/uro.2022.014.
Download citation

References

  1. Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016;40(2):244-252. Go to original source... Go to PubMed...
  2. Broďák M, Košina J, Balík M, et al. Robotem asistovaná radikální prostatektomie, zkušenosti po provedení prvních 50 operací. Urol. praxi. 2017;18(3):129-132. Go to original source...
  3. Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79(2):243-262. Go to original source... Go to PubMed...
  4. Lowrance WT, Eastham JA, Savage C, et al. Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J Urol. 2012;187(6):2087-2092. Go to original source... Go to PubMed...
  5. Oberlin DT, Flum AS, Lai JD, Meeks JJ. The effect of minimally invasive prostatectomy on practice patterns of American urologists. Urol Oncol. 2016;34(6):255 e1-5. Go to original source... Go to PubMed...
  6. McAlpine K, Forster AJ, Breau RH, et al. Robotic surgery improves transfusion rate and perioperative outcomes using a broad implementation process and multiple surgeon learning curves. Can Urol Assoc J. 2019;13(6):184-189. Go to original source... Go to PubMed...
  7. Preisser F, Busto Martin L, Pompe RS, et al. Effect of bladder neck sparing at robot-assisted laparoscopic prostatectomy on postoperative continence rates and biochemical recurrence. Urol Oncol. 2020;38(1):1.e11-1.e16. Go to original source... Go to PubMed...
  8. Sooriakumaran P, Pini G, Nyberg T, et al. Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol. 2018;73(4):618-627. Go to original source... Go to PubMed...
  9. Basiri A, de la Rosette JJ, Tabatabaei S, et al. Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner? World J Urol. 2018;36(4):609-621. Go to original source... Go to PubMed...
  10. Porena M, Mearini E, Mearini L, et al. Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency. Eur Urol. 2007;52:38-45. Go to original source... Go to PubMed...
  11. Gomha MA, Boone TB. Voiding patterns in patients with post-prostatectomy incontinence: urodynamic and demographic analysis. J Urol. 2003;169:1766-1769. Go to original source... Go to PubMed...
  12. Giannantoni A, Mearini E, Di Stasi SM, et al. Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. J Urol. 2004;171: 1563-1566. Go to original source... Go to PubMed...
  13. Ficazzola MA, Nitti VW. The etiology of postradical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol. 1998;160:1317-1320. Go to original source... Go to PubMed...
  14. Winters JC, Appell RA, Rackley RR. Urodynamic findings in postprostatectomy incontinence. Neurourol Urodyn. 1998; 17:493-498. Go to original source...
  15. Leach GE, Trockman B, Wong A, et al. Post-prostatectomy incontinence: urodynamic findings and treatment outcomes. J Urol. 1996;155:1256-1259. Go to original source... Go to PubMed...
  16. Chao R, Mayo ME. Incontinence after radical prostatectomy: detrusor or sphincter causes. J Urol. 1995;154:16-18. Go to original source... Go to PubMed...
  17. Giannantoni A, Mearini E, Di Stasi SM, et al. Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. J Urol. 2004;171:1563-1566. Go to original source... Go to PubMed...
  18. Groutz A, Blaivas JG, Chaikin DC, et al. The pathophysiology of post-radical prostatectomy incontinence: a clinical and video urodynamic study. J Urol. 2000;163:1767-1770. Go to original source... Go to PubMed...
  19. Peyronnet B, Brucker BM. Management of Overactive Bladder Symptoms After Radical Prostatectomy. Curr Urol Rep. 2018;19(12):95. Go to original source... Go to PubMed...
  20. Sakalis V, Gkotsi A. Do Drugs Work for ΟΑΒ Following Prostate Cancer Surgery. Curr Drug Targets. 2020;21(15):1515-1526. Go to original source... Go to PubMed...
  21. Ryšánková M. Konzervativní léčba inkontinence moči po radikální prostatektomii. Urol. praxi. 2015;16(4):157-158.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.